A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma

Phase 2

Ziopharm